www.pharma-summit.com Kindly supported by Between Innovation and Regulation 4 th International Summit October 6 th and 7 th 2015 Sofitel Berlin Kurfürstendamm Prof David Haslam National Institute for Health and Care Excellence (NICE) Dr Jan Hille Siemens Healthcare Dr Werner Lanthaler Evotec Martha Carruthers Janssen Healthcare Innovation Dr Gerd Maass Roche Pharma Discuss tomorrow’s ideas of healthcare innovation with: 2 days of future insights in the healthcare business Inspiring speeches and thought-provoking panel discussions on Networking highlights 20+ high-level speakers from around the world Innovation sourcing • Business model innovation • Regulative barriers Speed networking • Roundtables • Evening event Martine Zimmermann Alexion Pharma International ... amongst others!
Transcript
www.pharma-summit.com
EUROFORUM Deutschland SE, Postfach 11 12 34, 40512 Düsseldorf, Germany
VENUE
Sofitel Berlin Kurfürstendamm
Augsburger Straße 4110789 Berlin, GermanyPhone: +49 (0)30/800 999 0
A limited number of rooms is available at the conference hotel at a reduced rate. Please contact the hotel directly to make your reservation quoting the reference EUROFORUM. The room contingent expires four weeks before the conference starts.
The Sofitel Berlin Kurfürstendamm cordially invites to an aperitif on the first conference day.
DATA PR OTEC T I O N. EUROFORUM Deutschland SE uses the data col-lected in connection with your order and use of our services and products within the applicable legal limits for the purpose of performing our ser-vices, and to provide you with infor-mation by post and e-mail about fur-ther offers by us, companies of our Group or co-operation partners, which are similar to the services of which you availed yourself previous-ly. If, during the use of the data, it is transmitted to countries lacking an adequate level of data protection, we will create sufficient guarantees to protect the data. Furthermore, we will use your data if you have given us your consent to do so. You may object to the use of your data for advertising purposes or to being contacted by email or fax at any time by contacting EUROFORUM Deutschland SE, Post-fach 11 12 34, 40512 Düsseldorf, Germany. Our customer services (Phone: +49 (0)2 11.96 86 – 33 33) shall be pleased to accept requests for changes.
The participation fee for the event includes conference materials, lunch, refreshments, excl. VAT per person and is payable upon receipt of invoice. A substitute may attend in your place at no additional cost, please do inform us of any changes.
Complete terms and conditions are available online at:
http://www.euroforum.de/agben
PRICES Early bird rate available until July 31st 2015
Standard rate:
Summit October 6th and 7th 2015
€ 1,849* € 2,099*
* excl. VAT per person[P1106849]
www.pharma-summit.com
Kindly supported by
Between Innovation and Regulation
4th International Summit
October 6th and 7th 2015Sofitel Berlin Kurfürstendamm
Prof David Haslam National Institute for Health and Care Excellence (NICE)
Dr Jan Hille Siemens Healthcare
Dr Werner Lanthaler Evotec
Martha Carruthers Janssen Healthcare Innovation
Dr Gerd Maass Roche Pharma
Discuss tomorrow’s ideas of healthcare innovation with:
2 days of future insights in the healthcare business
Inspiring speeches and thought-provoking panel discussions on
Networking highlights
20+ high-level speakers from around the world
Innovation sourcing • Business model innovation • Regulative barriers
Speed networking • Roundtables • Evening event
Martine Zimmermann Alexion Pharma International ... amongst
others!
www.pharma-summit.com
CEOs, Directors, Leaders,
General Managers and experts across pharma’s value chain, especially from the departments• Business development• Innovation and strategy• Strategic alliances and
collaborations• Outsourcing and
externalisation• Market access • R&D• Product and brand
management / marketing
This Summit will gather senior leaders from inside and outside the healthcare sector to discuss how innovation can be created and stimulated. Following the success of our past events of this series, this year’s Summit
will feature a range of keynotes as well as interactive panel discussions and hands-on sessions offering you
lots of opportunities to connect and collaborate with peers. The focus is set on getting new inspirations for innovative ideas in the healthcare business as well as meeting non-traditional entrants of the industry
to bring your company’s innovative ideas with the best partner to the next stage.
There’s a lot to talk about: Health 2.0, connected health, remote care, personalised medicine... What healthcare really needs are ways to become smarter.Chris Isler, former Global Head of Solution & Product Development, Pfizer Integrated Healthcare
In times of fast moving business models and new technologies shaking up the traditional healthcare industry, it’s even more crucial to source and manage innovative ideas effectively and sustainably. Collaborations are seen as one promising option to raise finance amid, share potential risks, boost research productivity and outcomes, discover new therapies – And therefore ultimately to reinvent the way healthcare is delivered.
WHO SHOULD ATTEND:
WHY YOU SHOULD JOIN:
This year’s Summit “Rethinking Healthcare” will broach the issue of how innovation may be sourced and will also highlight ground-breaking collaborations and best practice examples along pharma’s value chain. Furthermore, the conference will tackle regulative barriers and guidelines that are still hindering the implementation of smart ideas.
October 6th and 7th 2015, Sofitel Berlin Kurfürstendamm
360° Perspective – Meet thought leaders and innovation experts
Save 250 € with
our early bird rate
www.pharma-summit.com www.pharma-summit.com
AGENDA | DAY ONE, TUESDAY OCTOBER 6th 2015
8.00 Registration and networking breakfast
8.30 SPEED NETWORKING SESSION Collaboration starts here: Use our speed networking session to get to know who is with you at the event right from the start. Bring plenty of business cards to take part in the fastest, most benefi cial and enjoyable 30 minutes of networking you will ever join!
9.00 CHAIR’S WELCOME
Dr Michael C. Müller, Managing Partner, Cepton Stratgies/CRA
INNOVATION MANAGEMENT IN HEALTHCAREINNOVATION SOURCING
9.15 OPENING KEYNOTEDisruptive times: What will healthcare innovation look like in 2025?• Demand will continue to outstrip supply in healthcare• Changing patterns of disease and the challenges these
bring• If we can’t know the future, what can we be certain of?
Prof David Haslam, Chair, National Institute for Health and Care Excellence (NICE)
9.45 KEYNOTEManaging innovation in healthcare
Chris Moore, Life Sciences EMEIA Lead Partner, EMEIA Advisory, EY
10.15 BEST PRACTICE & WEBCASTCreating an innovation culture: The Florida Hospital Innovation Lab & Princeton Warehouse
Stefan W. Herzberg, Co-Founder andKaren Tilstra, Co-Founder, Florida Hospital Innovation Lab – FHIL
10.45 VISIONStimulating smart research by PPPs: The Innovative Medicines Initiative
BUSINESS MODEL INNOVATIONTHE NEXT GENERATION R&D COLLABORATION
11.45New entrants on the horizon: How pharma and biotech can work together in new paradigms
Dr Werner Lanthaler, CEO, Evotec
12.15 Molecular diagnostics and targeted cancer treatments – Towards a unified approach by pharma and academia
Dr Gerd Maass, Head of Strategic Partnerships, Roche Pharma
12.45 Approaches to foster collaborations in early drug discovery
Prof Stefan Jaroch, Head External Innovation Technologies, Global External Innovation & Alliances, Bayer Pharma
13.15 LUNCH
OPEN INNOVATION
14.15Project Data Sphere: Sharing information and making data transparent in oncology trials
Dr Martin J. Murphy, CEO, CEO Roundtable on Cancer
14.45Enrolling patients in clinical trials – The TrialReach Project of Pfizer, Novartis and Eli Lilly
Robert Kroes, Project Lead Clinical Open Innovation Europe,Eli Lilly
BOOSTING DEVELOPMENT IN PARTNERSHIPS
15.15 PANEL DISCUSSIONFelix Gutsche, Corporate Development Strategy, Boehringer Ingelheim (invited)Dr Jan Hille, Director Strategy, Business Development and M&A, Siemens Healthcaren.n.
16.00 NETWORKING BREAK
16.30 New form of alliance: How big data supports disease manage-ment, population health and drug development
Nitzan Sneh, CEO, CliniWorks
CAPTURING ALL COMMERCIALISATION AND MARKETING CHANNELS BY PARTNERING
17.00Joining forces in marketing: How stakeholders share each other’s core competencies to address patients’ needs and commercialise new products
Martine Zimmermann, VP Global Regulatory Affairs, Alexion Pharma International
17.30 New ways of drug application and patient monitoring: How technology improves therapy outcomes
Dr Alexander Schachinger, CEO, EPatient RSD
18.00 CHAIR’S CLOSING REMARKS AND END OF DAY ONE
Dr Michael C. Müller
GET-TOGETHER EVENING EVENT
2 3
DAY TWO | WEDNESDAY, OCTOBER 7th 2015
8.30 Welcome with coff ee and tea
9.00 CHAIR’S WELCOME
Gerd W. Stürz, Market Segment Leader Life Sciences, Healthcare and Chemicals, Germany, Switzerland and Austria, EY
MHEALTH: MULTIPLYING INNOVATION BY TECHNOLOGY
9.15 Digital health: Patient services, health literacy and adherence
Eddie Chan, Global Head Search & Evaluation, Sanofi
9.45Patient engagement and beyond
Peter Aksel Villadsen, Senior Director Global Patient Engagement, LEO Pharma
10.15 mHealth – Nice to have or the next brilliant coup in healthcare?
Dr. Urs C.H. Wiedemann, VP, Cepton Strategies/CRA
11.05 NETWORKING BREAK
REGULATIONS IN HEALTHCARE INNOVATION
11.30 KEYNOTEChallenges in healthcare innovation – Facts and future
Lutz J. Völker, CEO, Molecular Health
Interested in moderatingROUNDTALE 3?Get in touch withAnnette Schwartze
12.00 PANEL DISCUSSIONMistrust, data restriction, difficulties in valuation – What are the main barriers that are still hindering ground-breaking ideas in healthcare?
Martha Carruthers, Global Marketing Director, Janssen Healthcare InnovationDr Hans Hofstraat, VP, Innovation Manager and Member of the HealthTech Programme Board, Philips ResearchDr Volker Möckel, Senior Global Trial Leader, Novartis
12.45 ROUNDTABLE SESSION – SHARE YOUR EXPERIENCES AND GET NEW INSIGHTS
ROUNDTABLE 1: Innovation sourcingWhat are the best ways and strategies to get fresh ideas for your future business? How can innovation be stimulated?
Moderated by Dr Michael C. Müller
ROUNDTABLE 2: New kids on the block – Does the future of healthcare belong to new market entrants?IT companies and start-ups are working together with pharma companies across the whole value chain. Do players have to collaborate to succeed?
Moderated by Jürgen Peukert, Partner, EY
ROUNDTABLE 3: Innovation barriersHow might we overstep regulative hurdles and challenges to boost innovation?
13.30 PRESENTATION OF THE ROUNDTABLE RESULTS
13.45 CHAIR’S FIVE TAKE-AWAYSGerd W. Stürz
14.00 – 15.00 FLYING LUNCH AND END OF THE SUMMIT
MEDIA PARTNERS
CONFERENCE PARTNER
Follow us on twitter @events_health#rethinkhealth
Join our LinkedIn GroupRethinking Healthcare – International Summithttp://tuq.in/Lr9E
Make it your eventBECOME A SPONSOR OF THE SUMMIT!
We offer various packages of marketing and sponsoring opportunities tailored to your personal needs. Let’s discuss your ideas!
Life sciences companies are facing challenging but promising times, as business models evolve, stakeholder expectations increase, new markets emerge, demographics shift, new technologies flourish, populations age and health care expenditures rise. EY‘s Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential – a team with deep technical experience in providing assurance, tax, transaction and advisory services. The Center works to anticipate market trends identify the implications and develop points of view on relevant industry issues. It’s how EY makes a difference. For more information, please visit www.ey.com/lifesciences or email [email protected].
www.ey.com
COMPANY PRESENTATION
Berlin Partner for Business and TechnologyBusiness and technology support for companies, investors and scientific institutions in Berlin. With customized services and an excellent science and research network, our many experts provide an outstanding range of programs to help companies launch, innovate, expand and secure their economic future in Berlin.
www.pharma-summit.com www.pharma-summit.com
AGENDA | DAY ONE, TUESDAY OCTOBER 6th 2015
8.00 Registration and networking breakfast
8.30 SPEED NETWORKING SESSION Collaboration starts here: Use our speed networking session to get to know who is with you at the event right from the start. Bring plenty of business cards to take part in the fastest, most benefi cial and enjoyable 30 minutes of networking you will ever join!
9.00 CHAIR’S WELCOME
Dr Michael C. Müller, Managing Partner, Cepton Stratgies/CRA
INNOVATION MANAGEMENT IN HEALTHCAREINNOVATION SOURCING
9.15 OPENING KEYNOTEDisruptive times: What will healthcare innovation look like in 2025?• Demand will continue to outstrip supply in healthcare• Changing patterns of disease and the challenges these
bring• If we can’t know the future, what can we be certain of?
Prof David Haslam, Chair, National Institute for Health and Care Excellence (NICE)
9.45 KEYNOTEManaging innovation in healthcare
Chris Moore, Life Sciences EMEIA Lead Partner, EMEIA Advisory, EY
10.15 BEST PRACTICE & WEBCASTCreating an innovation culture: The Florida Hospital Innovation Lab & Princeton Warehouse
Stefan W. Herzberg, Co-Founder andKaren Tilstra, Co-Founder, Florida Hospital Innovation Lab – FHIL
10.45 VISIONStimulating smart research by PPPs: The Innovative Medicines Initiative
BUSINESS MODEL INNOVATIONTHE NEXT GENERATION R&D COLLABORATION
11.45New entrants on the horizon: How pharma and biotech can work together in new paradigms
Dr Werner Lanthaler, CEO, Evotec
12.15 Molecular diagnostics and targeted cancer treatments – Towards a unified approach by pharma and academia
Dr Gerd Maass, Head of Strategic Partnerships, Roche Pharma
12.45 Approaches to foster collaborations in early drug discovery
Prof Stefan Jaroch, Head External Innovation Technologies, Global External Innovation & Alliances, Bayer Pharma
13.15 LUNCH
OPEN INNOVATION
14.15Project Data Sphere: Sharing information and making data transparent in oncology trials
Dr Martin J. Murphy, CEO, CEO Roundtable on Cancer
14.45Enrolling patients in clinical trials – The TrialReach Project of Pfizer, Novartis and Eli Lilly
Robert Kroes, Project Lead Clinical Open Innovation Europe,Eli Lilly
BOOSTING DEVELOPMENT IN PARTNERSHIPS
15.15 PANEL DISCUSSIONFelix Gutsche, Corporate Development Strategy, Boehringer Ingelheim (invited)Dr Jan Hille, Director Strategy, Business Development and M&A, Siemens Healthcaren.n.
16.00 NETWORKING BREAK
16.30 New form of alliance: How big data supports disease manage-ment, population health and drug development
Nitzan Sneh, CEO, CliniWorks
CAPTURING ALL COMMERCIALISATION AND MARKETING CHANNELS BY PARTNERING
17.00Joining forces in marketing: How stakeholders share each other’s core competencies to address patients’ needs and commercialise new products
Martine Zimmermann, VP Global Regulatory Affairs, Alexion Pharma International
17.30 New ways of drug application and patient monitoring: How technology improves therapy outcomes
Dr Alexander Schachinger, CEO, EPatient RSD
18.00 CHAIR’S CLOSING REMARKS AND END OF DAY ONE
Dr Michael C. Müller
GET-TOGETHER EVENING EVENT
2 3
DAY TWO | WEDNESDAY, OCTOBER 7th 2015
8.30 Welcome with coff ee and tea
9.00 CHAIR’S WELCOME
Gerd W. Stürz, Market Segment Leader Life Sciences, Healthcare and Chemicals, Germany, Switzerland and Austria, EY
MHEALTH: MULTIPLYING INNOVATION BY TECHNOLOGY
9.15 Digital health: Patient services, health literacy and adherence
Eddie Chan, Global Head Search & Evaluation, Sanofi
9.45Patient engagement and beyond
Peter Aksel Villadsen, Senior Director Global Patient Engagement, LEO Pharma
10.15 mHealth – Nice to have or the next brilliant coup in healthcare?
Dr. Urs C.H. Wiedemann, VP, Cepton Strategies/CRA
11.05 NETWORKING BREAK
REGULATIONS IN HEALTHCARE INNOVATION
11.30 KEYNOTEChallenges in healthcare innovation – Facts and future
Lutz J. Völker, CEO, Molecular Health
Interested in moderatingROUNDTALE 3?Get in touch withAnnette Schwartze
12.00 PANEL DISCUSSIONMistrust, data restriction, difficulties in valuation – What are the main barriers that are still hindering ground-breaking ideas in healthcare?
Martha Carruthers, Global Marketing Director, Janssen Healthcare InnovationDr Hans Hofstraat, VP, Innovation Manager and Member of the HealthTech Programme Board, Philips ResearchDr Volker Möckel, Senior Global Trial Leader, Novartis
12.45 ROUNDTABLE SESSION – SHARE YOUR EXPERIENCES AND GET NEW INSIGHTS
ROUNDTABLE 1: Innovation sourcingWhat are the best ways and strategies to get fresh ideas for your future business? How can innovation be stimulated?
Moderated by Dr Michael C. Müller
ROUNDTABLE 2: New kids on the block – Does the future of healthcare belong to new market entrants?IT companies and start-ups are working together with pharma companies across the whole value chain. Do players have to collaborate to succeed?
Moderated by Jürgen Peukert, Partner, EY
ROUNDTABLE 3: Innovation barriersHow might we overstep regulative hurdles and challenges to boost innovation?
13.30 PRESENTATION OF THE ROUNDTABLE RESULTS
13.45 CHAIR’S FIVE TAKE-AWAYSGerd W. Stürz
14.00 – 15.00 FLYING LUNCH AND END OF THE SUMMIT
MEDIA PARTNERS
CONFERENCE PARTNER
Follow us on twitter @events_health#rethinkhealth
Join our LinkedIn GroupRethinking Healthcare – International Summithttp://tuq.in/Lr9E
Make it your eventBECOME A SPONSOR OF THE SUMMIT!
We offer various packages of marketing and sponsoring opportunities tailored to your personal needs. Let’s discuss your ideas!
Life sciences companies are facing challenging but promising times, as business models evolve, stakeholder expectations increase, new markets emerge, demographics shift, new technologies flourish, populations age and health care expenditures rise. EY‘s Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential – a team with deep technical experience in providing assurance, tax, transaction and advisory services. The Center works to anticipate market trends identify the implications and develop points of view on relevant industry issues. It’s how EY makes a difference. For more information, please visit www.ey.com/lifesciences or email [email protected].
www.ey.com
COMPANY PRESENTATION
Berlin Partner for Business and TechnologyBusiness and technology support for companies, investors and scientific institutions in Berlin. With customized services and an excellent science and research network, our many experts provide an outstanding range of programs to help companies launch, innovate, expand and secure their economic future in Berlin.
www.pharma-summit.com www.pharma-summit.com
AGENDA | DAY ONE, TUESDAY OCTOBER 6th 2015
8.00 Registration and networking breakfast
8.30 SPEED NETWORKING SESSION Collaboration starts here: Use our speed networking session to get to know who is with you at the event right from the start. Bring plenty of business cards to take part in the fastest, most benefi cial and enjoyable 30 minutes of networking you will ever join!
9.00 CHAIR’S WELCOME
Dr Michael C. Müller, Managing Partner, Cepton Stratgies/CRA
INNOVATION MANAGEMENT IN HEALTHCAREINNOVATION SOURCING
9.15 OPENING KEYNOTEDisruptive times: What will healthcare innovation look like in 2025?• Demand will continue to outstrip supply in healthcare• Changing patterns of disease and the challenges these
bring• If we can’t know the future, what can we be certain of?
Prof David Haslam, Chair, National Institute for Health and Care Excellence (NICE)
9.45 KEYNOTEManaging innovation in healthcare
Chris Moore, Life Sciences EMEIA Lead Partner, EMEIA Advisory, EY
10.15 BEST PRACTICE & WEBCASTCreating an innovation culture: The Florida Hospital Innovation Lab & Princeton Warehouse
Stefan W. Herzberg, Co-Founder andKaren Tilstra, Co-Founder, Florida Hospital Innovation Lab – FHIL
10.45 VISIONStimulating smart research by PPPs: The Innovative Medicines Initiative
BUSINESS MODEL INNOVATIONTHE NEXT GENERATION R&D COLLABORATION
11.45New entrants on the horizon: How pharma and biotech can work together in new paradigms
Dr Werner Lanthaler, CEO, Evotec
12.15 Molecular diagnostics and targeted cancer treatments – Towards a unified approach by pharma and academia
Dr Gerd Maass, Head of Strategic Partnerships, Roche Pharma
12.45 Approaches to foster collaborations in early drug discovery
Prof Stefan Jaroch, Head External Innovation Technologies, Global External Innovation & Alliances, Bayer Pharma
13.15 LUNCH
OPEN INNOVATION
14.15Project Data Sphere: Sharing information and making data transparent in oncology trials
Dr Martin J. Murphy, CEO, CEO Roundtable on Cancer
14.45Enrolling patients in clinical trials – The TrialReach Project of Pfizer, Novartis and Eli Lilly
Robert Kroes, Project Lead Clinical Open Innovation Europe,Eli Lilly
BOOSTING DEVELOPMENT IN PARTNERSHIPS
15.15 PANEL DISCUSSIONFelix Gutsche, Corporate Development Strategy, Boehringer Ingelheim (invited)Dr Jan Hille, Director Strategy, Business Development and M&A, Siemens Healthcaren.n.
16.00 NETWORKING BREAK
16.30 New form of alliance: How big data supports disease manage-ment, population health and drug development
Nitzan Sneh, CEO, CliniWorks
CAPTURING ALL COMMERCIALISATION AND MARKETING CHANNELS BY PARTNERING
17.00Joining forces in marketing: How stakeholders share each other’s core competencies to address patients’ needs and commercialise new products
Martine Zimmermann, VP Global Regulatory Affairs, Alexion Pharma International
17.30 New ways of drug application and patient monitoring: How technology improves therapy outcomes
Dr Alexander Schachinger, CEO, EPatient RSD
18.00 CHAIR’S CLOSING REMARKS AND END OF DAY ONE
Dr Michael C. Müller
GET-TOGETHER EVENING EVENT
2 3
DAY TWO | WEDNESDAY, OCTOBER 7th 2015
8.30 Welcome with coff ee and tea
9.00 CHAIR’S WELCOME
Gerd W. Stürz, Market Segment Leader Life Sciences, Healthcare and Chemicals, Germany, Switzerland and Austria, EY
MHEALTH: MULTIPLYING INNOVATION BY TECHNOLOGY
9.15 Digital health: Patient services, health literacy and adherence
Eddie Chan, Global Head Search & Evaluation, Sanofi
9.45Patient engagement and beyond
Peter Aksel Villadsen, Senior Director Global Patient Engagement, LEO Pharma
10.15 mHealth – Nice to have or the next brilliant coup in healthcare?
Dr. Urs C.H. Wiedemann, VP, Cepton Strategies/CRA
11.05 NETWORKING BREAK
REGULATIONS IN HEALTHCARE INNOVATION
11.30 KEYNOTEChallenges in healthcare innovation – Facts and future
Lutz J. Völker, CEO, Molecular Health
Interested in moderatingROUNDTALE 3?Get in touch withAnnette Schwartze
12.00 PANEL DISCUSSIONMistrust, data restriction, difficulties in valuation – What are the main barriers that are still hindering ground-breaking ideas in healthcare?
Martha Carruthers, Global Marketing Director, Janssen Healthcare InnovationDr Hans Hofstraat, VP, Innovation Manager and Member of the HealthTech Programme Board, Philips ResearchDr Volker Möckel, Senior Global Trial Leader, Novartis
12.45 ROUNDTABLE SESSION – SHARE YOUR EXPERIENCES AND GET NEW INSIGHTS
ROUNDTABLE 1: Innovation sourcingWhat are the best ways and strategies to get fresh ideas for your future business? How can innovation be stimulated?
Moderated by Dr Michael C. Müller
ROUNDTABLE 2: New kids on the block – Does the future of healthcare belong to new market entrants?IT companies and start-ups are working together with pharma companies across the whole value chain. Do players have to collaborate to succeed?
Moderated by Jürgen Peukert, Partner, EY
ROUNDTABLE 3: Innovation barriersHow might we overstep regulative hurdles and challenges to boost innovation?
13.30 PRESENTATION OF THE ROUNDTABLE RESULTS
13.45 CHAIR’S FIVE TAKE-AWAYSGerd W. Stürz
14.00 – 15.00 FLYING LUNCH AND END OF THE SUMMIT
MEDIA PARTNERS
CONFERENCE PARTNER
Follow us on twitter @events_health#rethinkhealth
Join our LinkedIn GroupRethinking Healthcare – International Summithttp://tuq.in/Lr9E
Make it your eventBECOME A SPONSOR OF THE SUMMIT!
We offer various packages of marketing and sponsoring opportunities tailored to your personal needs. Let’s discuss your ideas!
Life sciences companies are facing challenging but promising times, as business models evolve, stakeholder expectations increase, new markets emerge, demographics shift, new technologies flourish, populations age and health care expenditures rise. EY‘s Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential – a team with deep technical experience in providing assurance, tax, transaction and advisory services. The Center works to anticipate market trends identify the implications and develop points of view on relevant industry issues. It’s how EY makes a difference. For more information, please visit www.ey.com/lifesciences or email [email protected].
www.ey.com
COMPANY PRESENTATION
Berlin Partner for Business and TechnologyBusiness and technology support for companies, investors and scientific institutions in Berlin. With customized services and an excellent science and research network, our many experts provide an outstanding range of programs to help companies launch, innovate, expand and secure their economic future in Berlin.
www.pharma-summit.com
EUROFORUM Deutschland SE, Postfach 11 12 34, 40512 Düsseldorf, Germany
VENUE
Sofitel Berlin Kurfürstendamm
Augsburger Straße 4110789 Berlin, GermanyPhone: +49 (0)30/800 999 0
A limited number of rooms is available at the conference hotel at a reduced rate. Please contact the hotel directly to make your reservation quoting the reference EUROFORUM. The room contingent expires four weeks before the conference starts.
The Sofitel Berlin Kurfürstendamm cordially invites to an aperitif on the first conference day.
DATA PR OTEC T I O N. EUROFORUM Deutschland SE uses the data col-lected in connection with your order and use of our services and products within the applicable legal limits for the purpose of performing our ser-vices, and to provide you with infor-mation by post and e-mail about fur-ther offers by us, companies of our Group or co-operation partners, which are similar to the services of which you availed yourself previous-ly. If, during the use of the data, it is transmitted to countries lacking an adequate level of data protection, we will create sufficient guarantees to protect the data. Furthermore, we will use your data if you have given us your consent to do so. You may object to the use of your data for advertising purposes or to being contacted by email or fax at any time by contacting EUROFORUM Deutschland SE, Post-fach 11 12 34, 40512 Düsseldorf, Germany. Our customer services (Phone: +49 (0)2 11.96 86 – 33 33) shall be pleased to accept requests for changes.
The participation fee for the event includes conference materials, lunch, refreshments, excl. VAT per person and is payable upon receipt of invoice. A substitute may attend in your place at no additional cost, please do inform us of any changes.
Complete terms and conditions are available online at:
http://www.euroforum.de/agben
PRICES Early bird rate available until July 31st 2015
Standard rate:
Summit October 6th and 7th 2015
€ 1,849* € 2,099*
* excl. VAT per person[P1106849]
www.pharma-summit.com
Kindly supported by
Between Innovation and Regulation
4th International Summit
October 6th and 7th 2015Sofitel Berlin Kurfürstendamm
Prof David Haslam National Institute for Health and Care Excellence (NICE)
Dr Jan Hille Siemens Healthcare
Dr Werner Lanthaler Evotec
Martha Carruthers Janssen Healthcare Innovation
Dr Gerd Maass Roche Pharma
Discuss tomorrow’s ideas of healthcare innovation with:
2 days of future insights in the healthcare business
Inspiring speeches and thought-provoking panel discussions on
Networking highlights
20+ high-level speakers from around the world
Innovation sourcing • Business model innovation • Regulative barriers
Speed networking • Roundtables • Evening event
Martine Zimmermann Alexion Pharma International ... amongst
others!
www.pharma-summit.com
CEOs, Directors, Leaders,
General Managers and experts across pharma’s value chain, especially from the departments• Business development• Innovation and strategy• Strategic alliances and
collaborations• Outsourcing and
externalisation• Market access • R&D• Product and brand
management / marketing
This Summit will gather senior leaders from inside and outside the healthcare sector to discuss how innovation can be created and stimulated. Following the success of our past events of this series, this year’s Summit
will feature a range of keynotes as well as interactive panel discussions and hands-on sessions offering you
lots of opportunities to connect and collaborate with peers. The focus is set on getting new inspirations for innovative ideas in the healthcare business as well as meeting non-traditional entrants of the industry
to bring your company’s innovative ideas with the best partner to the next stage.
There’s a lot to talk about: Health 2.0, connected health, remote care, personalised medicine... What healthcare really needs are ways to become smarter.Chris Isler, former Global Head of Solution & Product Development, Pfizer Integrated Healthcare
In times of fast moving business models and new technologies shaking up the traditional healthcare industry, it’s even more crucial to source and manage innovative ideas effectively and sustainably. Collaborations are seen as one promising option to raise finance amid, share potential risks, boost research productivity and outcomes, discover new therapies – And therefore ultimately to reinvent the way healthcare is delivered.
WHO SHOULD ATTEND:
WHY YOU SHOULD JOIN:
This year’s Summit “Rethinking Healthcare” will broach the issue of how innovation may be sourced and will also highlight ground-breaking collaborations and best practice examples along pharma’s value chain. Furthermore, the conference will tackle regulative barriers and guidelines that are still hindering the implementation of smart ideas.
October 6th and 7th 2015, Sofitel Berlin Kurfürstendamm
360° Perspective – Meet thought leaders and innovation experts
Save 250 € with
our early bird rate
www.pharma-summit.com
EUROFORUM Deutschland SE, Postfach 11 12 34, 40512 Düsseldorf, Germany
VENUE
Sofitel Berlin Kurfürstendamm
Augsburger Straße 4110789 Berlin, GermanyPhone: +49 (0)30/800 999 0
A limited number of rooms is available at the conference hotel at a reduced rate. Please contact the hotel directly to make your reservation quoting the reference EUROFORUM. The room contingent expires four weeks before the conference starts.
The Sofitel Berlin Kurfürstendamm cordially invites to an aperitif on the first conference day.
DATA PR OTEC T I O N. EUROFORUM Deutschland SE uses the data col-lected in connection with your order and use of our services and products within the applicable legal limits for the purpose of performing our ser-vices, and to provide you with infor-mation by post and e-mail about fur-ther offers by us, companies of our Group or co-operation partners, which are similar to the services of which you availed yourself previous-ly. If, during the use of the data, it is transmitted to countries lacking an adequate level of data protection, we will create sufficient guarantees to protect the data. Furthermore, we will use your data if you have given us your consent to do so. You may object to the use of your data for advertising purposes or to being contacted by email or fax at any time by contacting EUROFORUM Deutschland SE, Post-fach 11 12 34, 40512 Düsseldorf, Germany. Our customer services (Phone: +49 (0)2 11.96 86 – 33 33) shall be pleased to accept requests for changes.
The participation fee for the event includes conference materials, lunch, refreshments, excl. VAT per person and is payable upon receipt of invoice. A substitute may attend in your place at no additional cost, please do inform us of any changes.
Complete terms and conditions are available online at:
http://www.euroforum.de/agben
PRICES Early bird rate available until July 31st 2015
Standard rate:
Summit October 6th and 7th 2015
€ 1,849* € 2,099*
* excl. VAT per person[P1106849]
www.pharma-summit.com
Kindly supported by
Between Innovation and Regulation
4th International Summit
October 6th and 7th 2015Sofitel Berlin Kurfürstendamm
Prof David Haslam National Institute for Health and Care Excellence (NICE)
Dr Jan Hille Siemens Healthcare
Dr Werner Lanthaler Evotec
Martha Carruthers Janssen Healthcare Innovation
Dr Gerd Maass Roche Pharma
Discuss tomorrow’s ideas of healthcare innovation with:
2 days of future insights in the healthcare business
Inspiring speeches and thought-provoking panel discussions on
Networking highlights
20+ high-level speakers from around the world
Innovation sourcing • Business model innovation • Regulative barriers
Speed networking • Roundtables • Evening event
Martine Zimmermann Alexion Pharma International ... amongst
others!
www.pharma-summit.com
CEOs, Directors, Leaders,
General Managers and experts across pharma’s value chain, especially from the departments• Business development• Innovation and strategy• Strategic alliances and
collaborations• Outsourcing and
externalisation• Market access • R&D• Product and brand
management / marketing
This Summit will gather senior leaders from inside and outside the healthcare sector to discuss how innovation can be created and stimulated. Following the success of our past events of this series, this year’s Summit
will feature a range of keynotes as well as interactive panel discussions and hands-on sessions offering you
lots of opportunities to connect and collaborate with peers. The focus is set on getting new inspirations for innovative ideas in the healthcare business as well as meeting non-traditional entrants of the industry
to bring your company’s innovative ideas with the best partner to the next stage.
There’s a lot to talk about: Health 2.0, connected health, remote care, personalised medicine... What healthcare really needs are ways to become smarter.Chris Isler, former Global Head of Solution & Product Development, Pfizer Integrated Healthcare
In times of fast moving business models and new technologies shaking up the traditional healthcare industry, it’s even more crucial to source and manage innovative ideas effectively and sustainably. Collaborations are seen as one promising option to raise finance amid, share potential risks, boost research productivity and outcomes, discover new therapies – And therefore ultimately to reinvent the way healthcare is delivered.
WHO SHOULD ATTEND:
WHY YOU SHOULD JOIN:
This year’s Summit “Rethinking Healthcare” will broach the issue of how innovation may be sourced and will also highlight ground-breaking collaborations and best practice examples along pharma’s value chain. Furthermore, the conference will tackle regulative barriers and guidelines that are still hindering the implementation of smart ideas.
